Steven W. Pipe, MD

home / authors / steven-w-pipe-md

Director, Pediatric Hemophilia and Coagulation Disorders Program, CS Mott Children's Hospital, and professor, University of Michigan Health

Articles

Steven W. Pipe, MD, a professor of pediatric hematology/oncology at CS Mott Children’s Hospital

Evaluating siRNA Therapy Fitusiran in Combination With Antithrombin Modulation for Hemophilia

Steven W. Pipe, MD;Noah Stansfield;Victoria Johnson

December 19th 2024

Steven W. Pipe, MD, a professor of pediatric hematology/oncology at CS Mott Children’s Hospital, discussed findings from the open-label extension of the ATLAS studies at ASH 2024.

Steven W. Pipe, MD, on Evaluating siRNA Therapy Fitusiran in Combination With Antithrombin Modulation for Hemophilia

Steven W. Pipe, MD;Victoria Johnson

December 11th 2024

The professor of pediatric hematology/oncology at CS Mott Children’s Hospital discussed findings from the open-label extension of the ATLAS studies at ASH 2024.

Steven W. Pipe, MD, on Confirming Efficacy, Safety of Hemgenix Gene Therapy in Hemophilia B Populations

Steven W. Pipe, MD

June 5th 2024

The professor of pediatric hematology/oncology at CS Mott Children’s Hospital discussed a sub analysis of the HOPE-B trial.

Steven W. Pipe, MD, on Data Continuing to Support Etranacogene Dezaparvovec Over SOC in Hemophilia B

Steven W. Pipe, MD

December 12th 2023

The professor of pediatric hematology/oncology at CS Mott Children’s Hospital discussed 3-year follow-up data from the HOPE B trial of the approved gene therapy, branded as Hemgenix.

Steven Pipe, MD, on Continuing Durability of Etranacogene Dezaparvovec in Hemophilia B

Steven W. Pipe, MD

December 17th 2022

The professor of pediatric hematology/oncology at CS Mott Children’s Hospital discussed new follow-up data from the HOPE-B study presented at ASH 2022.

Steven W. Pipe, MD, on Conducting Further Research in Hemophilia

Steven W. Pipe, MD

July 26th 2022

The director of the Pediatric Hemophilia and Coagulation Disorders Program at CS Mott Children’s Hospital discussed current studies evaluating gene therapies in hemophilia.

Steven W. Pipe, MD, on Challenges in Gene Therapy Trials for Hemophilia

Steven W. Pipe, MD

June 24th 2022

The director of the Pediatric Hemophilia and Coagulation Disorders Program at CS Mott Children’s Hospital discussed common challenges with gene therapy clinical trials.

Gene Therapy Potential in Hemophilia: Steven W. Pipe, MD

Steven W. Pipe, MD

March 15th 2022

The director of the Pediatric Hemophilia and Coagulation Disorders Program at CS Mott Children’s Hospital discussed research with AAV gene therapy in hemophilia.

Unmet Needs in Hemophilia: Steven W. Pipe, MD

Steven W. Pipe, MD

February 22nd 2022

The director of the Pediatric Hemophilia and Coagulation Disorders Program at CS Mott Children’s Hospital discussed the advantages of AAV gene therapies.